Ansell (ANSLY) Stock Price, News & Analysis

Company Overview

Ansell Limited is an Australian company that develops, manufactures and distributes personal protective equipment (PPE). Its products are designed to help protect workers and healthcare professionals from chemical, biological, mechanical and other workplace hazards.

The company’s portfolio includes disposable and surgical gloves, examination gloves, reusable industrial gloves, chemical-protective gloves, protective clothing and other specialized safety products. Its brands include MICROFLEX, TouchNTuff, GAMMEX, AlphaTec, HyFlex, ActivArmr and Ringers. Ansell serves customers in healthcare, life sciences, manufacturing, automotive, chemical processing, oil and gas, food processing and other industrial markets.

Ansell traces its origins to 1929 and has expanded from its Australian beginnings into a global PPE provider serving customers across North America, Europe, Asia-Pacific, Latin America and other international markets. The company is headquartered in Melbourne, Australia, and is led by Chief Executive Officer and Managing Director Neil Salmon.

Key Stats

• Today's Range: $124.00 to $124.00
• 50-Day Range: $84.09 to $124.00
• 52-Week Range: $74.38 to $124.00
• Volume: 127 shs
• Average Volume: 183 shs
• Market Capitalization: N/A
• P/E Ratio: 100.36
• Dividend Yield: 0.57%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Ansell Stock Analysis - MarketRank™

Ansell scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Ansell has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Ansell has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ansell is 100.36, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.94.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ansell is 100.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.98.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Ansell has a short interest ratio ("days to cover") of 2.36, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ansell has recently increased by 1,200.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Ansell pays a meaningful dividend of 1.96%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Ansell does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Ansell is 56.91%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Ansell this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ansell insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.60% of the stock of Ansell is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ANSLY
• CIK: N/A
• Web: www.ansell.com
• Phone: (139) 270-7270
• Fax: N/A
• Employees: 14,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 100.36
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A